弥合抗菌药物耐药性监测到管理的差距:全球经验叙述性综述
该综述提出「监测到管理差距」(S2S Gap)概念,分析WHO GLASS、英国ESPAUR及中低收入国家数据,指出耐药监测扩张快于行动转化。在55个南中心成员国中仅27%(15/55)同时报告耐药与抗菌药物使用数据;英国使用量下降2%但耐药未降。文章提出五阶段S2S框架以指导分阶段干预。
要点
- S2S差距指监测数据未能转化为管理行动,在不同卫生系统成熟度下表现不同。
- 仅27%(15/55)南中心成员国同时报告耐药和抗菌药物使用两类GLASS数据。
- 英国抗菌药物使用下降2%但耐药未相应下降,现有数据无法区分原因。
核心结论
- 耐药持续上升而监测扩张未转化为管理行动,核心约束是监测到管理差距(S2S Gap)。
- 弥合差距需像资助数据生成一样刻意资助数据转化,并实证评估S2S框架。
研究设计与样本
- 叙述性综述,整合WHO GLASS参与横断面分析(55个南中心成员国)、英国ESPAUR 2019-2024数据、印度/尼日利亚/孟加拉国实施研究及三项系统综述。
主要发现
- 27%(15/55)南中心成员国同时报告耐药和抗菌药物使用两类GLASS数据。
- 英国抗菌药物使用下降2%,但耐药尚未随之下降,现有数据无法区分原因。
- 六个结构性驱动因素(多层级治理、诊断、人力、资金、行为、实施能力)解释差距持续。
- 南非案例显示可在流程层面缩小差距。
关键数值与推荐
- S2S框架为五阶段路径,从监测到结局,对齐CFIR、RE-AIM和One Health视角。
- 27%(15/55)南中心成员国同时报告两类GLASS数据,其余监测不完整。
临床怎么用
- 用S2S框架诊断卫生系统所处阶段并靶向干预,而非仅扩大监测。
- 对WHO、政府、卫生系统和资助方分别提出行动建议以弥合差距。
局限性
- 为叙述性综述,非系统评价,未提供定量合并效应或偏倚评估。
- 英国使用下降2%与耐药未降的因果关系受限于现有数据无法区分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance surveillance has expanded faster than any other component of the global response, yet resistance continues to rise. In a growing number of settings, the principal constraint is the failure to translate available data into action, a disconnect we describe as the Surveillance-to-Stewardship (S2S) Gap. OBJECTIVES: To define the S2S Gap and its component gaps, examine where it binds across health systems of different maturity, analyse why it persists, and propose an operationalizable, testable framework for closing it. SOURCES: A cross-sectional analysis of WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) participation across all 55 South Centre member states; the UK English Surveillance Programme for Antimicrobial Utilisation and Resistance programme (2019-2024); published implementation studies from India, Nigeria, and Bangladesh, read alongside three sector-specific systematic syntheses conducted by our group, all now published; and comparative governance analyses and implementation-science frameworks. CONTENT: Adopting the GLASS conception of surveillance (resistance plus antimicrobial use data), the gap recurs but binds at different stages by system maturity: as incomplete surveillance in many low- and middle-income countries (27% [15/55] of the states report both data types), as absent operational stewardship machinery despite near-universal awareness and policy, and as uncertain policy-to-outcome translation in the mature UK system, where a 2% fall in use has not yet been accompanied by falling resistance, for reasons that current data cannot distinguish. Six structural drivers (multilevel governance, diagnostics, workforce, financing, behaviour, and implementation capacity) explain persistence. South Africa illustrates process-level narrowing. The S2S Framework, a five-stage pathway from surveillance to outcomes aligned with Consolidated Framework for Implementation Research, Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM), and a One Health perspective, enables stage diagnosis and targeted intervention. IMPLICATIONS: Closing the gap requires funding translation as deliberately as data generation, with actions for WHO, governments, health systems, and funders, and an explicit agenda for empirically evaluating the framework itself.
引用
- Elshenawy RA, Cernaliu A, Abe OM, et al. Closing the Surveillance-to-Stewardship Gap in antimicrobial resistance: a narrative review of global lessons from WHO GLASS, UK ESPAUR, and low- and middle-income countries. Clin Microbiol Infect. 2026. PMID: 42805292. doi:10.1016/j.cmi.2026.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。